propranolol has been researched along with chitosan in 31 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (3.23) | 18.7374 |
1990's | 3 (9.68) | 18.2507 |
2000's | 12 (38.71) | 29.6817 |
2010's | 11 (35.48) | 24.3611 |
2020's | 4 (12.90) | 2.80 |
Authors | Studies |
---|---|
Bodmeier, R; Chen, HG; Paeratakul, O | 1 |
Rao, KP; Thacharodi, D | 2 |
Alonso, MJ; Portero, A; Remuñán-López, C; Vila-Jato, JL | 1 |
Bigucci, F; Cerchiara, T; Luppi, B; Orienti, I; Zecchi, V | 1 |
Deasy, PB; Levis, SR | 1 |
Phaechamud, T; Ritthidej, GC | 2 |
Bigucci, F; Cerchiara, T; Chidichimo, G; Luppi, B; Zecchi, V | 1 |
Patel, JK; Patel, MM; Patel, VM; Prajapati, BG | 1 |
Charlton, ST; Davis, SS; Illum, L | 1 |
Govender, T; Lutchman, D; Mackraj, I; Perumal, VA | 1 |
Amnuaikit, C; Bodhibukkana, C; Kaewnopparat, S; Srichana, T; Suedee, R; Tangthong, N | 1 |
Ramakrishnan, A; Vasanthakumar, S; Vijayaraghavan, C | 1 |
Bostanian, LA; Chinta, DD; Graves, RA; Mandal, TK; Pamujula, S; Praetorius, N | 1 |
Patel, MM; Patel, VM; Prajapati, BG | 1 |
Devanga-Chinta, D; Graves, RA; Mandal, TK; Pamujula, S | 1 |
Khunawattanakul, W; Pongjanyakul, T; Puttipipatkhachorn, S; Rades, T | 2 |
Ketjinda, W; Mitrevej, A; Sinchaipanid, N; Tuntikulwattana, S; Williams, DB | 1 |
Cavallo, JA; Chuliá-Jordán, R; Gómez, C; Guzmán, E; Ortega, F; Rubio, RG; Strumia, MC | 1 |
Aziz, US; Rasool, AA; Rasool, BK; Sarheed, O | 1 |
Chen, B; Justin, R | 1 |
Indana, VL; Kumar, J; Newton, AM | 1 |
Abruzzo, A; Bigucci, F; Cerchiara, T; Gallucci, MC; Luppi, B | 1 |
Al-Kassas, R; Cheng, AE; Kim, AM; Liu, SSM; Wen, J; Yu, J | 1 |
Abruzzo, A; Bigucci, F; Cerchiara, T; Dalena, F; Luppi, B; Nicoletta, FP | 1 |
Abo El-Ela, FI; El-Banna, HA; El-Nesr, KA; El-Shahawy, AAG; Khaled, E; Zanaty, MI | 1 |
AbouSamra, MM; El Arini, SK; El-Gazaerly, ON; Elbary, AA; Khalil, RM; Zaki, HS | 1 |
Samadifar, M; Yamini, Y | 1 |
Amiri, H; Khorshidvand, Z; Maghsood, AH; Shirian, S; Zamani, A | 1 |
31 other study(ies) available for propranolol and chitosan
Article | Year |
---|---|
A novel approach to the oral delivery of micro- or nanoparticles.
Topics: Alginates; Calcium Chloride; Chemistry, Pharmaceutical; Chitin; Chitosan; Microscopy, Electron, Scanning; Microspheres; Particle Size; Powders; Propranolol | 1989 |
Development and in vitro evaluation of chitosan-based transdermal drug delivery systems for the controlled delivery of propranolol hydrochloride.
Topics: Administration, Cutaneous; Animals; Anticholesteremic Agents; Chitin; Chitosan; Diffusion; Drug Delivery Systems; Epidermis; Evaluation Studies as Topic; Hemostatics; Membranes, Artificial; Permeability; Propranolol; Rabbits; Skin | 1995 |
Propranolol hydrochloride release behaviour of crosslinked chitosan membranes.
Topics: Calorimetry, Differential Scanning; Chitin; Chitosan; Cross-Linking Reagents; Delayed-Action Preparations; Diffusion; Membranes, Artificial; Permeability; Propranolol; Tensile Strength; Thermogravimetry | 1993 |
Design and evaluation of chitosan/ethylcellulose mucoadhesive bilayered devices for buccal drug delivery.
Topics: Adhesives; Animals; Cattle; Cellulose; Cheek; Chitin; Chitosan; Drug Delivery Systems; Evaluation Studies as Topic; Microscopy, Electron; Nifedipine; Propranolol | 1998 |
Physically cross-linked chitosan hydrogels as topical vehicles for hydrophilic drugs.
Topics: Administration, Cutaneous; Animals; Chitin; Chitosan; Cross-Linking Reagents; Freeze Drying; Hydrogels; In Vitro Techniques; Laurates; Magnetic Resonance Spectroscopy; Myristates; Palmitates; Permeability; Pharmaceutical Vehicles; Propranolol; Skin Absorption; Solubility; Spectroscopy, Fourier Transform Infrared; Stearates; Swine; Viscosity | 2002 |
Use of coated microtubular halloysite for the sustained release of diltiazem hydrochloride and propranolol hydrochloride.
Topics: Acrylates; Aluminum Silicates; Chitin; Chitosan; Clay; Cyanoacrylates; Delayed-Action Preparations; Diltiazem; Hydrogen-Ion Concentration; Microscopy, Electron, Scanning; Polyethyleneimine; Polymers; Propranolol; Solubility; Surface Properties; Thermogravimetry | 2003 |
Effect of anionic water-soluble dyes on film coating properties of chitosan acetate.
Topics: Anions; Chitin; Chitosan; Coloring Agents; Compressive Strength; Drug Carriers; Drug Compounding; Hot Temperature; Kinetics; Powders; Propranolol; Solubility; Spectroscopy, Fourier Transform Infrared; Tablets, Enteric-Coated; Time Factors; Viscosity; Water | 2003 |
Chitosan and poly(methyl vinyl ether-co-maleic anhydride) microparticles as nasal sustained delivery systems.
Topics: Adhesiveness; Administration, Intranasal; Chitosan; Drug Delivery Systems; Hydrogen-Ion Concentration; Maleates; Microspheres; Polyethylenes; Propranolol; Solubility; Spectroscopy, Fourier Transform Infrared | 2005 |
Physicochemical characterization and evaluation of buccal adhesive patches containing propranolol hydrochloride.
Topics: Adhesiveness; Administration, Buccal; Animals; Biological Availability; Chitosan; Delayed-Action Preparations; Drug Delivery Systems; Drug Stability; Humans; Hydrogen-Ion Concentration; Mouth Mucosa; Povidone; Propranolol; Propylene Glycol; Saliva; Sheep; Surface Properties; Water | 2006 |
Evaluation of bioadhesive polymers as delivery systems for nose to brain delivery: in vitro characterisation studies.
Topics: Adhesiveness; Administration, Intranasal; Animals; Benzofurans; Brain; Cell Line; Cell Membrane Permeability; Central Nervous System Agents; Chemistry, Pharmaceutical; Chitosan; Delayed-Action Preparations; Diffusion; Dogs; Drug Carriers; Drug Compounding; Epithelial Cells; Gels; Kinetics; Mannitol; Methylation; Models, Chemical; Molecular Weight; Nasal Mucosa; Pectins; Polymers; Propranolol; Solubility; Tissue Adhesives; Viscosity | 2007 |
Sustained-release from layered matrix system comprising chitosan and xanthan gum.
Topics: Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Chitosan; Delayed-Action Preparations; Hydrogen-Ion Concentration; Kinetics; Lactose; Microscopy, Electron, Scanning; Polysaccharides, Bacterial; Propranolol; Spectroscopy, Fourier Transform Infrared; Tablets | 2007 |
Formulation of monolayered films with drug and polymers of opposing solubilities.
Topics: Acrylic Resins; Adrenergic beta-Antagonists; Chemistry, Pharmaceutical; Chitosan; Drug Compounding; Excipients; Half-Life; Hardness; Hydrogen-Ion Concentration; Kinetics; Pharmaceutical Preparations; Propranolol; Reproducibility of Results; Solubility; Surface Properties; Tissue Adhesives | 2008 |
Development of a reservoir-type transdermal enantioselective-controlled delivery system for racemic propranolol using a molecularly imprinted polymer composite membrane.
Topics: Adrenergic beta-Antagonists; Animals; Area Under Curve; Cellulose; Chitosan; Delayed-Action Preparations; Drug Delivery Systems; Drug Evaluation, Preclinical; Gels; Hydrogen-Ion Concentration; Male; Membranes, Artificial; Microscopy, Confocal; Molecular Weight; Polymers; Propranolol; Rats; Rats, Wistar; Skin Absorption; Stereoisomerism; Temperature; Viscosity | 2008 |
In vitro and in vivo evaluation of locust bean gum and chitosan combination as a carrier for buccal drug delivery.
Topics: Adhesiveness; Administration, Buccal; Adrenergic beta-Antagonists; Adult; Biological Availability; Chemistry, Pharmaceutical; Chitosan; Data Interpretation, Statistical; Drug Carriers; Galactans; Humans; Hydrogen-Ion Concentration; Male; Mannans; Plant Gums; Propranolol | 2008 |
Spray-dried chitosan as a direct compression tableting excipient.
Topics: Chemistry, Pharmaceutical; Chitosan; Citric Acid; Excipients; Lactose; Molecular Weight; Particle Size; Propranolol; Sodium Bicarbonate; Tablets; Technology, Pharmaceutical; Temperature | 2009 |
Design and characterization of chitosan-containing mucoadhesive buccal patches of propranolol hydrochloride.
Topics: Adhesiveness; Adhesives; Adolescent; Adrenergic beta-Antagonists; Adult; Algorithms; Animals; Cheek; Chitosan; Drug Design; Female; Humans; Hydrogen-Ion Concentration; In Vitro Techniques; Male; Middle Aged; Mouth Mucosa; Pharmaceutic Aids; Povidone; Propranolol; Saliva; Sheep; Young Adult | 2007 |
Controlled release multiple layer coatings.
Topics: Cellulose; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Drug Compounding; Excipients; Propranolol; Surface Properties; Tablets, Enteric-Coated | 2010 |
Chitosan-magnesium aluminum silicate nanocomposite films: physicochemical characterization and drug permeability.
Topics: Acetaminophen; Aluminum Compounds; Aluminum Silicates; Calorimetry, Differential Scanning; Chemistry, Pharmaceutical; Chitosan; Diclofenac; Diffusion; Drug Carriers; Drug Compounding; Hydrogen Bonding; Magnesium; Magnesium Compounds; Nanocomposites; Permeability; Pliability; Powder Diffraction; Propranolol; Silicates; Solubility; Spectroscopy, Fourier Transform Infrared; Surface Properties; Tablets; Technology, Pharmaceutical; Temperature; Tensile Strength; Water | 2010 |
Novel chitosan-magnesium aluminum silicate nanocomposite film coatings for modified-release tablets.
Topics: Acetaminophen; Aluminum Compounds; Aluminum Silicates; Chitosan; Drug Stability; Excipients; Hydrogen-Ion Concentration; Intestinal Secretions; Magnesium; Magnesium Compounds; Nanocomposites; Propranolol; Silicates; Solubility; Tablets | 2011 |
Fabrication of chitosan--polyacrylic acid complexes as polymeric osmogents for swellable micro/nanoporous osmotic pumps.
Topics: Acrylic Resins; Chitosan; Drug Delivery Systems; Models, Theoretical; Nanostructures; Osmosis; Polymers; Propranolol; Solubility; Spectroscopy, Fourier Transform Infrared; Tablets | 2011 |
pH-induced changes in the fabrication of multilayers of poly(acrylic acid) and chitosan: fabrication, properties, and tests as a drug storage and delivery system.
Topics: Acoustics; Acrylic Resins; Adsorption; Chitosan; Drug Carriers; Drug Storage; Elasticity; Hydrogen-Ion Concentration; Kinetics; Models, Molecular; Molecular Conformation; Optical Phenomena; Propranolol | 2011 |
Design and evaluation of a bioadhesive film for transdermal delivery of propranolol hydrochloride.
Topics: Adhesives; Administration, Cutaneous; Animals; Antihypertensive Agents; Benzalkonium Compounds; Chitosan; Delayed-Action Preparations; Drug Compounding; Drug Delivery Systems; Drug Evaluation, Preclinical; Excipients; Male; Oleic Acid; Permeability; Polysorbates; Propranolol; Rats; Rats, Wistar; Skin; Skin Absorption; Surface-Active Agents; Terpenes; Time Factors | 2011 |
Characterisation and drug release performance of biodegradable chitosan-graphene oxide nanocomposites.
Topics: Adrenergic beta-Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Chitosan; Cisplatin; Drug Delivery Systems; Graphite; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Indomethacin; Nanocomposites; Oxides; Propranolol; Surface Properties; Timolol | 2014 |
Chronotherapeutic drug delivery of Tamarind gum, Chitosan and Okra gum controlled release colon targeted directly compressed Propranolol HCl matrix tablets and in-vitro evaluation.
Topics: Abelmoschus; Acrylic Resins; Animals; Chitosan; Colon; Delayed-Action Preparations; Drug Chronotherapy; Drug Compounding; Drug Liberation; Kinetics; Plant Gums; Propranolol; Rats; Tablets; Tamarindus | 2015 |
Mucoadhesive Buccal Tablets Based on Chitosan/Gelatin Microparticles for Delivery of Propranolol Hydrochloride.
Topics: Adhesiveness; Administration, Buccal; Animals; Chemistry, Pharmaceutical; Chitosan; Drug Carriers; Drug Delivery Systems; Gelatin; Microspheres; Mouth Mucosa; Propranolol; Swine; Tablets | 2015 |
Transdermal delivery of propranolol hydrochloride through chitosan nanoparticles dispersed in mucoadhesive gel.
Topics: Adhesives; Administration, Cutaneous; Adrenergic beta-Antagonists; Animals; Chitosan; Drug Carriers; Gels; Nanoparticles; Propranolol; Skin; Skin Absorption; Swine | 2016 |
Bilayered buccal films as child-appropriate dosage form for systemic administration of propranolol.
Topics: Administration, Buccal; Child; Chitosan; Drug Delivery Systems; Gelatin; Humans; Mouth Mucosa; Propranolol | 2017 |
An Herbal Nanohybrid Formula of Epigallocatechin Gallate-Chitosan-Alginate Efficiently Restrict the Sexual Dysfunction Adverse Effect of
Topics: Adrenergic beta-Antagonists; Alginates; Animals; Catechin; Chitosan; Male; Nanostructures; Organ Size; Propranolol; Rats; Sexual Dysfunction, Physiological | 2020 |
Development of Lecithin/Chitosan Nanoparticles for Promoting Topical Delivery of Propranolol Hydrochloride: Design, Optimization and In-Vivo Evaluation.
Topics: Animals; Chitosan; Drug Carriers; Lecithins; Nanoparticles; Particle Size; Propranolol; Rats; Skin Absorption | 2021 |
Microextraction by packed sorbent of some β-blocker drugs with chitosan@mof-199 bio-composite in human saliva, plasma, and urine samples.
Topics: Chitosan; Chromatography, High Pressure Liquid; Humans; Limit of Detection; Propranolol; Saliva; Solid Phase Microextraction | 2023 |
Immunomodulatory chitosan nanoparticles for Toxoplasma gondii infection: Novel application of chitosan in complex propranolol-hydrochloride as an adjuvant in vaccine delivery.
Topics: Adjuvants, Immunologic; Adjuvants, Pharmaceutic; Animals; Antigens, Protozoan; Chitosan; Cytokines; Immunity, Cellular; Immunoglobulin G; Mice; Mice, Inbred BALB C; Propranolol; Protozoan Proteins; Protozoan Vaccines; Toxoplasma; Toxoplasmosis, Animal; Vaccines, DNA | 2023 |